Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

PLAINSBORO, N.J., March 3, 2025 /PRNewswire/ -- Novo Nordisk launched ... with type 2 diabetes with help from Ozempic ® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg, along with diet and exercise.

Novo Nordisk secures global rights (excluding China) for UBT251 in a $2B+ deal with United Biotechnology, advancing obesity ...

U.S.-listed shares of Novo Nordisk, which produces obesity drugs Ozempic and Wegovy ... injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at local pharmacies for $499 per month.

1 mg, 1.7 mg and 2.4 mg. In addition to the home delivery capabilities, the drugmaker said NovoCare will support patients with benefit verification, refill reminders as well as access to live support ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...